Citation: Mb. Boffa et al., PLASMA AND RECOMBINANT THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR (TAFI) AND ACTIVATED TAFI COMPARED WITH RESPECT TO GLYCOSYLATION, THROMBINTHROMBOMODULIN-DEPENDENT ACTIVATION, THERMAL-STABILITY, AND ENZYMATIC-PROPERTIES/, The Journal of biological chemistry, 273(4), 1998, pp. 2127-2135
Citation: Mb. Boffa et Me. Nesheim, ANALYSIS OF A RECOMBINANT FORM OF HUMAN TAFI (PLASMA PROCARBOXYPEPTIDASE-B) CONTAINING AN ARG-]GLN SUBSTITUTION AT THE INACTIVATION CLEAVAGE SITE, Thrombosis and haemostasis, 1997, pp. 2433-2433
Authors:
SANGRAR W
GABEL BR
BOFFA MB
WALKER JB
HANCOCK MA
MARCOVINA SM
HORREVOETS AJG
NESHEIM ME
KOSCHINSKY ML
Citation: W. Sangrar et al., THE SOLUTION-PHASE INTERACTION BETWEEN APOLIPOPROTEIN(A) AND PLASMINOGEN INHIBITS THE BINDING OF PLASMINOGEN TO A PLASMIN-MODIFIED FIBRINOGEN SURFACE, Biochemistry, 36(34), 1997, pp. 10353-10363
Citation: J. Walker et al., COMPOSITION AND TPA COFACTOR ACTIVITY OF SOLUBLE FRAGMENTS RELEASED DURING PERFUSION OF CROSS-LINKED FIBRIN WITH PLASMIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1132-1132
Authors:
JONES BB
OHNO CK
ALLENBY G
BOFFA MB
LEVIN AA
GRIPPO JF
PETKOVICH M
Citation: Bb. Jones et al., NEW RETINOID-X RECEPTOR SUBTYPES IN ZEBRA FISH (DANIO-RERIO) DIFFERENTIALLY MODULATE TRANSCRIPTION AND DO NOT BIND 9-CIS RETINOIC ACID, Molecular and cellular biology, 15(10), 1995, pp. 5226-5234